Leptomeningeal carcinomatosis in patients with breast cancer
MA Franzoi, GN Hortobagyi - Critical reviews in oncology/hematology, 2019 - Elsevier
Leptomeningeal carcinomatosis (LC) is defined as infiltration of the leptomeninges by
metastatic carcinoma, a relatively uncommon but devastating complication of many …
metastatic carcinoma, a relatively uncommon but devastating complication of many …
[HTML][HTML] Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival
A Niwińska, H Rudnicka, M Murawska - Medical oncology, 2013 - Springer
The aim of the study was to define biological subtypes of breast cancer that have the
propensity to metastasize to the leptomeninges and to assess factors influencing survival …
propensity to metastasize to the leptomeninges and to assess factors influencing survival …
Leptomeningeal disease and breast cancer: the importance of tumor subtype
S Abouharb, J Ensor, ME Loghin, R Katz… - Breast cancer research …, 2014 - Springer
Breast cancer (BC) is one of the most common tumors to involve the leptomeninges. We
aimed to characterize clinical features and outcomes of patients with LMD based on BC …
aimed to characterize clinical features and outcomes of patients with LMD based on BC …
Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled …
F Zagouri, TN Sergentanis, R Bartsch… - Breast cancer research …, 2013 - Springer
Leptomeningeal carcinomatosis (MC) represents an uncommon, but devasting
manifestation of metastatic breast cancer. This is the first systematic review/pooled analysis …
manifestation of metastatic breast cancer. This is the first systematic review/pooled analysis …
Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report
HJ Stemmler, K Mengele, M Schmitt, N Harbeck… - Anti-cancer …, 2008 - journals.lww.com
Leptomeningeal carcinomatosis represents a rare manifestation of metastatic breast cancer
(MBC). We herewith report on a patient suffering from HER2 overexpressing MBC who …
(MBC). We herewith report on a patient suffering from HER2 overexpressing MBC who …
[HTML][HTML] Leptomeningeal metastasis in breast cancer–a systematic review
Background There is limited data on the impact of specific patient characteristics, tumor
subtypes or treatment interventions on survival in breast cancer LM. Methods A systematic …
subtypes or treatment interventions on survival in breast cancer LM. Methods A systematic …
[PDF][PDF] The diagnostic and therapeutic management of leptomeningeal carcinomatosis
N Pavlidis - Ann Oncol, 2004 - academia.edu
The infiltration of the leptomeninges by malignant cells is not an uncommon complication of
cancer and is called carcinomatous meningitis or leptomeningeal carcinomatosis (LC) …
cancer and is called carcinomatous meningitis or leptomeningeal carcinomatosis (LC) …
[HTML][HTML] A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
PF Wu, CH Lin, CH Kuo, WW Chen, DC Yeh, HW Liao… - BMC cancer, 2015 - Springer
Background Elevated vascular endothelial growth factor (VEGF) was associated with poor
prognosis in leptomeningeal carcinomatosis and anti-angiogenic therapy was found to …
prognosis in leptomeningeal carcinomatosis and anti-angiogenic therapy was found to …
Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations
S Lee, HK Ahn, YH Park, DH Nam, JI Lee… - Breast cancer research …, 2011 - Springer
Leptomeningeal metastasis (LM) usually occurs late during the course of breast cancer. The
aim of this study was to characterize the clinical features and outcomes of LM based on …
aim of this study was to characterize the clinical features and outcomes of LM based on …
Leptomeningeal carcinomatosis
SA Grossman, MJ Krabak - Cancer treatment reviews, 1999 - cancertreatmentreviews.com
Leptomeningeal carcinomatosis occurs in approximately 5% of patients with cancer. This
disorder is being diagnosed with increasing frequency as patients live longer and as neuro …
disorder is being diagnosed with increasing frequency as patients live longer and as neuro …
相关搜索
- breast cancer meningeal carcinomatosis
- breast cancer leptomeningeal metastasis
- breast cancer consecutive patients
- trastuzumab for the treatment meningeal carcinomatosis
- intrathecal administration meningeal carcinomatosis
- breast cancer tumor subtype
- breast cancer intrathecal administration
- breast cancer analysis of factors
- breast cancer trastuzumab for the treatment
- her2 overexpressing meningeal carcinomatosis
- consecutive patients leptomeningeal metastasis
- pooled analysis meningeal carcinomatosis
- breast cancer her2 overexpressing
- etoposide and cisplatin leptomeningeal carcinomatosis
- prognostic implications leptomeningeal carcinomatosis
- breast cancer leptomeningeal carcinomatosis